SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

112 hedge funds and large institutions have $27.7M invested in Sangamo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
-9
Holders Change %
-7.44%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
30
Reduced
32
Closed
24
Calls
$756K
Puts
$727K
Net Calls
+$29K
Net Calls Change
+$104K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$1.99M
2
GCP
GSA Capital Partners
United Kingdom
+$692K
3
WA
Wasatch Advisors
Utah
+$658K
4
UBS Group
UBS Group
Switzerland
+$345K
5
Squarepoint
Squarepoint
New York
+$332K

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.31M
2
OM
Opaleye Management
Massachusetts
-$692K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$561K
4
Millennium Management
Millennium Management
New York
-$437K
5
Marshall Wace
Marshall Wace
United Kingdom
-$430K
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
126
Prelude Capital Management
New York
– -$22.5K -34,382 Closed
SSA
127
Schonfeld Strategic Advisors
New York
– -$20.6K -31,425 Closed
SWM
128
Shelton Wealth Management
Texas
– -$18.4K -28,000 Closed
Wolverine Trading
129
Wolverine Trading
Illinois
– -$20.9K -25,486 Closed
LSIA
130
LaSalle St. Investment Advisors
Illinois
– -$12K -19,200 Closed
TC
131
TradeLink Capital
Illinois
– -$11K -16,200 Closed
CAS
132
CTC Alternative Strategies
Illinois
– -$10.4K -15,800 Closed
CM
133
Capula Management
Cayman Islands
– -$10.3K -15,690 Closed
Lazard Asset Management
134
Lazard Asset Management
New York
– -$1K -2,668 Closed
2 3 4 5
6